News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
mikro
Mikrobiomik receives the "Novel Company" award, granted by El Correo and Banco Sabadell
Corporate
El lunes 20 de febrero, la compañía fue galardonada con el premio “Empresa Novel”, dentro de la…
Partners - Mikrobiomik
ceisa
#NewMember | "A leading organization in terms of innovation which promotes collaboration and synergies between entities and leading companies in the sector."
Healthcare · Agrifood · Industrial biotechnology · Corporate
Meet CEISA, our new member. We talked to Josep Tascón,…
oryzin
Cash, cash equivalents and marketable securities totaled $22.7 million as of December 31, 2022
Corporate
Strong clinical progress in both oncology and CNS
Partners - Oryzon Genomics
asabys
Asabys announces the first close of its fund, with commitments of €100M, and appoints Sylvain Sachot and Guillem Masferrer as partners
Financing · Corporate
Banco Sabadell stands as the firm’s main private institutional investor, like in its previous fund…
Partners - Asabys Partners
telum
Telum Therapeutics names Vincent A. Fischetti chairman of its Scientific Advisory Board
Corporate
Professor Vincent A. Fischetti is the inventor of phage lysins as a new therapeutic and an…
Partners - TELUM THERAPEUTICS
apta
aptaTargets’ ApTOLL reduces mortality from 18% to 5% in a Phase 1b/2a trial in ischemic stroke patients
Healthcare · Corporate
 ApTOLL is the first TLR4 antagonist neuroprotectant to achieve positive efficacy endpoints in…
Partners - AptaTargets
ORYZON realizará múltiples actividades corporativas en conferencias internacionales en Febrero-Marzo
ORYZON to give updates on corporate progress in February-March
Healthcare
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company…
Partners - Oryzon Genomics
dolor
BCN HEALTH publishes a study assessing the incidence, mortality and hospital costs of ischemic heart disease in Spain
Healthcare · Corporate
BCN HEALTH ha publicado el estudio 'Burden of ischemic heart disease in Spain: incidence, hospital…
Partners - BCN Health
apta
AptaTargets awarded €2.5 million grant from Spanish government to evaluate ApTOLL for acute myocardial infarction
Healthcare · Access to innovation · Corporate
The funds are from a competitive call through the 2021 State Programme to Promote Scientific-…
Partners - AptaTargets